BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7092276)

  • 1. Pyoderma gangrenosum. Occurrence with altered cellular immunity and a circulating serum factor.
    Greenberg SJ; Jegasothy BV; Johnson RB; Lazarus GS
    Arch Dermatol; 1982 Jul; 118(7):498-502. PubMed ID: 7092276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pyoderma gangrenosum with altered cellular immunity and dermonecrotic factor.
    Delescluse J; De Bast C; Achten G
    Br J Dermatol; 1972 Dec; 87(6):529-32. PubMed ID: 4567639
    [No Abstract]   [Full Text] [Related]  

  • 4. Idiopathic pyoderma gangrenosum and impaired lymphocyte function: failure of azathioprine and corticosteroid therapy.
    Breathnach SM; Wells GC; Valdimarsson H
    Br J Dermatol; 1981 May; 104(5):567-73. PubMed ID: 7236516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis.
    Holt PJ; Davies MG; Saunders KC; Nuki G
    Medicine (Baltimore); 1980 Mar; 59(2):114-33. PubMed ID: 7360040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immune deficiences during pyoderma gangrenosum associated with a polycythemia vera].
    Deschamps P; Leroy D; Dresch C; Michel M
    Nouv Presse Med; 1977 Jun; 6(26):2339-41. PubMed ID: 887420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pyoderma Gangrenosum and rheumatoid arthritis.
    Stolman LP; Rosenthal D; Yaworsky R; Horan F
    Arch Dermatol; 1975 Aug; 111(8):1020-3. PubMed ID: 786171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selective immunoglobulin M (IgM) deficiency in two immunodeficient adults with recurrent staphylococcal pyoderma.
    Yocum MW; Strong DM; Chusid MJ; Lakin JD
    Am J Med; 1976 Apr; 60(4):486-94. PubMed ID: 1274982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T helper-suppressor cell imbalance in pyoderma gangrenosum, with relapsing polychondritis and corneal keratolysis.
    Check IJ; Ellington EP; Moreland A; McKay M
    Am J Clin Pathol; 1983 Sep; 80(3):396-9. PubMed ID: 6224416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyoderma gangrenosum and myeloproliferative disorders. Report of a case and review of the literature.
    Romano J; Safai B
    Arch Intern Med; 1979 Aug; 139(8):932-4. PubMed ID: 288320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pyoderma gangrenosum: Clofazimine therapy].
    Beurey J; Weber M; Delrous JL; Chaulieu Y
    Ann Dermatol Venereol; 1977 Oct; 104(10):631-4. PubMed ID: 610518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective monocyte function in pyoderma gangrenosum with IgG kappa paraproteinaemia.
    Jones RR; Kobza Black A; Donaghy M; Moshtael O; Pinching AJ
    Clin Exp Immunol; 1983 Jun; 52(3):685-92. PubMed ID: 6409473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pyoderma gangrenosum with IgA gammopathy.
    Murray JC
    Cutis; 1983 Nov; 32(5):477-80, 484-6. PubMed ID: 6360554
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pyoderma gangrenosum with cellular immunity defect and red cell aplasia.
    Clayton R
    Proc R Soc Med; 1977 Aug; 70(8):571-2. PubMed ID: 303364
    [No Abstract]   [Full Text] [Related]  

  • 15. Pyoderma gangrenosum with cellular immunity deficit treated with plasmaphoresis and leukocyte transfusion.
    Clayton R; Feiwel M; Valdimarsson H
    Br J Dermatol; 1976 Jul; 95 Suppl 14():67-8. PubMed ID: 1084156
    [No Abstract]   [Full Text] [Related]  

  • 16. In vitro studies on microphage functions in chronic pyoderma vegetans.
    Djawari D; Hornstein OP
    Arch Dermatol Res; 1978; 263(1):97-104. PubMed ID: 394690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a neutrophil chemotactic inhibitor in a patient with recurrent pyoderma.
    Robinson LD; Wooten SK; Kelly AP
    Arch Dermatol; 1979 Apr; 115(4):453-7. PubMed ID: 434868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Present status of pyoderma gangrenosum. Review of 21 cases.
    Prystowsky JH; Kahn SN; Lazarus GS
    Arch Dermatol; 1989 Jan; 125(1):57-64. PubMed ID: 2642682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mechanism of the inflammatory reactions in pyoderma].
    Lesnitskiĭ AI
    Vestn Dermatol Venerol; 1980 Jun; (6):10-6. PubMed ID: 7395360
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunosuppression in dogs with pyoderma and/or demodicosis.
    Toman M; Svoboda M; Rybnícek J; Krejcí J; Faldyna M; Bárta O
    Vet Med (Praha); 1997 Oct; 42(10):299-306. PubMed ID: 9416010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.